期刊文献+

对氧磷酶1基因Gln192Arg多态性与帕金森病的相关性

The correlation between Gln192Arg polymorphism in PON1 gene and Parkinson disease
下载PDF
导出
摘要 目的探讨中国汉族人群中对氧磷酶1(PON1)基因Gln192Arg单核苷酸多态性(SNP)与帕金森病(PD)的关系。方法采用等位基因特异性聚合酶链反应(A-S PCR)技术检测186例PD患者和228名健康对照PON1基因Gln192Arg位点SNP的分布,分析各基因型与患者发病年龄和疾病严重程度的关系。结果 PD组和对照组间基因型频率和等位基因频率比较差异均无统计学意义(χ2=0.56,P=0.76;χ2=0.06,P=0.81)。进一步按性别分层分析,两组相同性别间基因型和等位基因频率比较亦未发现有统计学差异存在(P>0.05)。PD患者各基因型与发病年龄和疾病严重程度亦无相关性。结论中国汉族人群中PON1基因Gln192Arg位点SNP与PD无相关性。 Objective To study the relationship between Gln192Arg single nucleotide polymorphism (SNP) in paraoxonase 1 (PON1) gene and Parkinson disease (PD) in Chinese Han population. Methods Gln192Arg SNP in PON1 gene was detected by Real Time PCR (A-S PCR) technique in 186 PD patients and 228 healthy controls. The relation between the age of onset and disease severity was analyzed. Results There was no significant difference in Gln192Arg PON1 genotype or allele frequencies between PD patients and controls (x^2= 0. 56, P=0.76; x^2 =0.06, P=0.81, respectively). When the PD group and the control group were stratified by sex, no significant difference in Gln192Arg PON1 genotype or allele frequencies was observed between this two groups (P〉0.05). There was no obvious association between the genotypes and the severity of the disease. Oneway ANOVA showed that PON1 genotype had no effect on the onset age of PD. Conclusions Gln192Arg SNP in PON1 gene was not associated with PD.
出处 《中国神经免疫学和神经病学杂志》 CAS 2011年第3期190-192,共3页 Chinese Journal of Neuroimmunology and Neurology
关键词 帕金森病 对氧磷酶1 基因表达 多态性 单核苷酸 Parkinson disease paraoxonase 1 gene expression polymorphism, single nucleotide
  • 相关文献

参考文献10

  • 1Zhou C,Huang Y,Przedborski S.Oxidative stress in Parkinson's disease:a mechanism of pathogenic and therapeutic significance[J].Ann NY Acad Sci,2008,1147:93-104.
  • 2Henchcliffe C,Beal MF.Mitochondrial biology and oxidative stress in Parkinson disease palhogenesis[J].Nat Clin Pract Neurol,2008,4(11):600-609.
  • 3Liu Y,Mackness B,Mackness M.Comparison of the ability of paraoxonases 1 and 3 to attenuate the in vitro oxidation of low-density lipoprotein and reduce macrophage oxidative stress[J].Free Radic Biol Med,2008,45(6):743-748.
  • 4Costa LG,Vitalone A,Cole TB,et al.Modulation of paraoxonase(PON1)activity[J].Biochem Pharmacol,2005,69(4):541-550.
  • 5Benmoyal-Segal L,Vander T,Shifman S,et al.Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease[J].FASEB J,2005,19 (3):452-454.
  • 6Clarimon J,Eerola J,Hellstrom O,et al.Paraoxonase 1 (PON1)gene polymorphisms and Parkinson's disease in a Finnish population[J].Neurosci Lett,2004,367(2):168-170.
  • 7Kelada SN,Costa-Mallen P,Checkoway H,et al.Paraoxonase 1 promoter and coding region polymorphisms in Parkinson's d isease[J].J Neurol Neurosurg Psychiatry,2003,74(4):546-547.
  • 8Kondo I,Yamamoto M.Genetic polymorphism of paraoxonase 1(PON1)and susceptibility to Parkinson's disease[J].Brain Res,1998,806:271-273.
  • 9Akhmedova SN,Yakimovsky AK,Schwartz EI.Paraoxonase 1 Met-Leu 54 polymorphism is associated with Parkinson's disease[J].J Neurol Sci,2001,184:179-182.
  • 10Carmine A,Buervenich S,Sydow O,et al.Further evidence for an association of the paraoxonase 1(PON1)Met-54 allele with Parkinson'S disease[J].Mov Disord,2002,17(4):764-786.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部